Online accounts of gene expression profiling in early-stage breast cancer: Interpreting genomic testing for chemotherapy decision making

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

(2018) Joseph A. Sparano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing

(2018) Lesley Fallowfield et al.   PSYCHO-ONCOLOGY

The UK’s 100,000 Genomes Project: manifesting policymakers’ expectations

(2017) Gabrielle Natalie Samuel et al.   NEW GENETICS AND SOCIETY

“It’s all very well reading the letters in the genome, but it’s a long way to being able to write”: Men’s interpretations of undergoing genetic profiling to determine future risk of prostate cancer

(2014) Elizabeth K. Bancroft et al.   Familial Cancer

Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives

(2013) Elizabeth Spellman et al.   PSYCHO-ONCOLOGY

Health and Illness in a Connected World: How Might Sharing Experiences on the Internet Affect People's Health?

(2012) SUE ZIEBLAND et al.   MILBANK QUARTERLY

Regulating diagnosis in post-genomic medicine: Re-aligning clinical judgment?

(2011) Pascale Bourret et al.   SOCIAL SCIENCE & MEDICINE

“I like to be an informed person but…” negotiating responsibility for treatment decisions in cancer care

(2010) Christina Sinding et al.   SOCIAL SCIENCE & MEDICINE

Fighting overtreatment in adjuvant breast cancer therapy

(2009) Michael Gnant et al.   LANCET

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

(2009) Kathy S Albain et al.   LANCET ONCOLOGY

‘If it almost kills you that means it's working!’ Cultural models of chemotherapy expressed in a cancer support group

(2008) Kirsten Bell   SOCIAL SCIENCE & MEDICINE